Leonard J. Brandt
Plus aucun poste en cours
Profil
Leonard J.
Brandt is the founder of Embro Vascular LLC (1999), Mill City Venture Consulting (1998), and MYnd Analytics, Inc. (1987).
At MYnd Analytics, Inc., he held the title of Chairman.
Mr. Brandt's former jobs include President & Chief Executive Officer at CNS California, Inc. (2000-2007), Chairman at Applied Biology, Inc., General Partner at Norwest Venture Partners (1983-1990), and President at Time Segment Publishing, Inc. (1995-1999).
Mr. Brandt's education includes an MBA from Harvard University and an undergraduate degree from the University of Illinois.
Anciens postes connus de Leonard J. Brandt
| Sociétés | Poste | Fin |
|---|---|---|
MYnd Analytics, Inc.
 MYnd Analytics, Inc. Services to the Health IndustryHealth Services MYnd Analytics, Inc. operates as a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. It provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioural disorders, includes depression, anxiety, bipolar disorder, post-traumatic stress disorder, and other non-psychotic disorders. The company was founded by Leonard J. Brandt and Brain McDonald on March 20, 1987 and is headquartered in Aliso Viejo, CA. | Fondateur | 01/08/2009 |
| CNS California, Inc. | President | 07/03/2007 |
| Time Segment Publishing, Inc. | President | 01/01/1999 |
Norwest Venture Partners
 Norwest Venture Partners Investment ManagersFinance Norwest Venture Partners is a venture capital division of Norwest Partners founded in 1961. The firm is headquartered in Palo Alto, California with additional offices in Mumbai and Herzliya. | Corporate Officer/Principal | 01/01/1990 |
Applied Biology, Inc.
 Applied Biology, Inc. BiotechnologyHealth Technology Applied Biology, Inc. develops drugs and medical devices for the treatment of hair disorders. The firm specializes on a topically applied prophylactic treatment for chemotherapy induced alopecia; a novel diagnostic device that can aid dermatologists in identifying non-responders to topical minoxidil; an adjuvant therapy for non-responders to topical minoxidil; and a novel therapy for female pattern hair loss. It offers product conceptualization and design, and regulatory and clinical studies services. The company was founded in 2002 and is headquartered in Irvine, CA. | Président | - |
Formation de Leonard J. Brandt
| University of Illinois | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
MYnd Analytics, Inc.
MYnd Analytics, Inc. Services to the Health IndustryHealth Services MYnd Analytics, Inc. operates as a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. It provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioural disorders, includes depression, anxiety, bipolar disorder, post-traumatic stress disorder, and other non-psychotic disorders. The company was founded by Leonard J. Brandt and Brain McDonald on March 20, 1987 and is headquartered in Aliso Viejo, CA. | Health Services |
| CNS California, Inc. | |
Norwest Venture Partners
Norwest Venture Partners Investment ManagersFinance Norwest Venture Partners is a venture capital division of Norwest Partners founded in 1961. The firm is headquartered in Palo Alto, California with additional offices in Mumbai and Herzliya. | Finance |
| Time Segment Publishing, Inc. | |
| Embro Vascular LLC | |
| Mill City Venture Consulting | |
Applied Biology, Inc.
Applied Biology, Inc. BiotechnologyHealth Technology Applied Biology, Inc. develops drugs and medical devices for the treatment of hair disorders. The firm specializes on a topically applied prophylactic treatment for chemotherapy induced alopecia; a novel diagnostic device that can aid dermatologists in identifying non-responders to topical minoxidil; an adjuvant therapy for non-responders to topical minoxidil; and a novel therapy for female pattern hair loss. It offers product conceptualization and design, and regulatory and clinical studies services. The company was founded in 2002 and is headquartered in Irvine, CA. | Health Technology |
